Company intelligence / Profile preview
Pharmos Corporation
Iselin, New Jersey, United Statespharmoscorp.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Dextofisopam showed statistically significant efficacy in IBS patients in Phase IIa. NanoEmulsion cream for topical NSAID delivery was also studied in osteoarthritis. The company’s synthetic cannabinoid platform demonstrated promising preclinical results for neuropathic pain and other indications. No recent clinical data available post-late 2000s.
- Therapeutic areas
- GastroenterologyImmunologyNeurologyRheumatology
- Modalities
- Small moleculesTopical drug delivery systems (NanoEmulsion cream)Synthetic cannabinoids/CB2-selective agonists
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
VenrockNew Enterprise Associates
Beyond the preview
Go deeper on Pharmos Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharmos Corporation.